Use of inhaled nitric oxide in preterm infants

Pediatrics

Volumn 133, Issue 1, 2014, Pages 164-170

  Kumar, Praveen ^a   Papile, Lu Ann ^a   Polin, Richard A ^a   Carlo, Waldemar A ^a   Tan, Rosemarie ^a   Benitz, William ^a   Eichenwald, Eric ^a   Cummings, James ^a   Baley, Jill ^a  

^a NONE

Author keywords

Bronchopulmonary dysplasia; Hypoxic respiratory failure; Inhaled nitric oxide; Preterm infants

Indexed keywords

NITRIC OXIDE; PLACEBO;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG USE; HUMAN; MAXIMAL EXPIRATORY FLOW; NERVE CELL DIFFERENTIATION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION;

EID: 84891792191     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3444     Document Type: Article

References (50)

1. American Academy of Pediatrics, Committee on Fetus and Newborn. American Academy of Pediatrics. Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics. 2000;106(2 pt 1): 344-345
2. Lin YJ, Markham NE, Balasubramaniam V, et al. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res. 2005;58(1): 22-29
3. McCurnin DC, Pierce RA, Chang LY, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2005;288(3): L450-L459
4. Ballard PL, Gonzales LW, Godinez RI, et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res. 2006;59(1): 157-162
5. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med. 2005;172(7): 899-906
6. Tang JR, Markham NE, Lin YJ, et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol. 2004;287(2):L344-L351
7. Clark RH, Ursprung RL, Walker MW, Ellsbury DL, Spitzer AR. The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit. J Perinatol. 2010;30 (12): 800-804
8. Cole FS, Alleyne C, Barks JD, et al. NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics. 2011;127(2): 363-369
9. Askie LM, Ballard RA, Cutter GR, et al Metaanalysis of Preterm Patients on Inhaled Nitric Oxide Collaboration. Inhaled nitric oxide in preterm infants: an individualpatient data meta-analysis of randomized trials. Pediatrics. 2011;128(4): 729-739
10. Skimming JW, Bender KA, Hutchison AA, Drummond WH. Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediatr. 1997;130(2): 225-230
11. Subhedar NV, Ryan SW, Shaw NJ. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;77(3):F185-F190
12. Kinsella JP, Walsh WF, Bose CL, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999; 354(9184): 1061-1065
13. The Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet. 1999; 354(9184): 1066-1071
14. Truffert P, Llado-Paris J, Mercier JC, Dehan M, Bréart G; Franco-Belgian iNO Study Group. Early inhaled nitric oxide in moderately hypoxemic preterm and term newborns with RDS: the RDS subgroup analysis of the Franco-Belgian iNO Randomized Trial. Eur J Pediatr. 2003;162(9): 646-647
15. Srisuparp P, Heitschmidt M, Schreiber MD. Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome. J Med Assoc Thai. 2002; 85(suppl 2):S469-S478
16. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349 (22): 2099-2107
17. Van Meurs KP, Wright LL, Ehrenkranz RA, et al Preemie Inhaled Nitric Oxide Study. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353(1): 13-22
18. Hascoet JM, Fresson J, Claris O, et al. The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr. 2005;146(3): 318-323
19. Field D, Elbourne D, Truesdale A, et al INNOVO Trial Collaborating Group. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339). Pediatrics. 2005;115(4): 926-936
20. Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355(4): 354-364
21. Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli FF. Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome. Acta Paediatr. 2006;95 (9): 1116-1123
22. Su PH, Chen JY. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure. J Perinatol. 2008; 28(2): 112-116
23. Van Meurs KP, Hintz SR, Ehrenkranz RA, et al. Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure. J Perinatol. 2007;27(6): 347-352
24. Ballard RA, Truog WE, Cnaan A, et al; NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355(4): 343-353
25. Mercier JC, Hummler H, Durrmeyer X, et al EUNO Study Group. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet. 2010;376(9738): 346-354
26. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163(7): 1723-1729
27. Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol. 2005;67: 623-661
28. Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, Abman SH. Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol. 2006; 291(1):L119-L127
29. Tang JR, Seedorf G, Balasubramaniam V, Maxey A, Markham N, Abman SH. Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition. Am J Physiol Lung Cell Mol Physiol. 2007;293(5):L1271-L1280
30. Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung injury: oxidantprotective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med. 1996;21(1): 43-52
31. Zhang YT, Zhang DL, Cao YL, Zhao BL. Developmental expression and activity variation of nitric oxide synthase in the brain of golden hamster. Brain Res Bull. 2002;58(4): 385-389
32. Soygüder Z, Karadag H, Nazli M. Neuronal nitric oxide synthase immunoreactivity in ependymal cells during early postnatal development. J Chem Neuroanat. 2004;27(1): 3-6
33. Cannon RO, III, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest. 2001;108(2): 279-287
34. McMahon TJ, Moon RE, Luschinger BP, et al. Nitric oxide in the human respiratory cycle. Nat Med. 2002;8(7): 711-717
35. Bennett AJ, Shaw NJ, Gregg JE, Subhedar NV. Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide. Acta Paediatr. 2001;90(5): 573-576
36. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005;353(1): 23-32
37. Huddy CL, Bennett CC, Hardy P, et al INNOVO Trial Collaborating Group. The INNOVO multicentre randomised controlled trial: neonatal ventilation with inhaled nitric oxide versus ventilatory support without nitric oxide for severe respiratory failure in preterm infants: follow up at 4-5 years. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):F430-F435
38. Hintz SR, Van Meurs KP, Perritt R, et al NICHD Neonatal Research Network. Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide. J Pediatr. 2007;151(1): 16-22, 22.e1-e3
39. Watson RS, Clermont G, Kinsella JP, et al Prolonged Outcomes After Nitric Oxide Investigators. Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year. Pediatrics. 2009; 124(5): 1333-1343
40. Walsh MC, Hibbs AM, Martin CR, et al; NO CLD Study Group. Two-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide. J Pediatr. 2010;156(4): 556-561.e1
41. Hibbs AM, Walsh MC, Martin RJ, et al. Oneyear respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial. J Pediatr. 2008;153(4): 525-529
42. Hoo AF, Beardsmore CS, Castle RA, et al INNOVO Trial Collaborating Group. Respiratory function during infancy in survivors of the INNOVO trial. Pediatr Pulmonol. 2009;44(2): 155-161
43. Barrington KJ, Finer N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2010;(12): CD000509
44. Donohue PK, Gilmore MM, Cristofalo E, et al. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics. 2011;127(2). Available at: www.pediatrics.org/cgi/content/full/127/2/e414
45. Zupancic JA, Hibbs AM, Palermo L, et al; NO CLD Trial Group. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics. 2009;124(5): 1325-1332
46. Truog WE, Ballard PL, Norberg M, et al Nitric Oxide (to Prevent) Chronic Lung Disease Study Investigators. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Pediatrics. 2007;119(4): 670-678
47. Ballard PL, Merrill JD, Truog WE, et al. Surfactant function and composition in premature infants treated with inhaled nitric oxide. Pediatrics. 2007;120(2): 346-353
48. Ballard PL, Truog WE, Merrill JD, et al. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics. 2008;121(3): 555-561
49. Posencheg MA, Gow AJ, Truog WE, et al; NO CLD Investigators. Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites. J Perinatol. 2010;30(4): 275-280
50. American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3): 874-877